BMGP - Biomagnetics Corp - Penny Stocks

admin · Tue, 03-11-2008, 04:15 PM

Current Project for Biomagnetics Diagnostics Corp

4:26p ET March 10, 2008 (Business Wire)

Biomagnetics Diagnostics Corporation (OTC:BMGP), announced today that is continuing formal negotiations to purchase an interest in Tianjin Automatic Science & Instrument Co. LTD.

1) Auto Science is located in Tianjin, China's third largest city with a population of 9.5 million. Tianjin is a major comprehensive industrial base in northern China. It has over 150 lines of industry consisting primarily of electronics, automobile, metallurgy, pharmaceuticals, textiles, chemicals and mechanics.

Tianjin Auto Science has been in business over 15 years. By acquiring an interest in Tianjin Auto Science, Biomagnetics Diagnostics will gain access to over 1,250 distributors, a laboratory client base of 10,000 and skilled manufacturing in the business community's most exciting markets.

2) We have received quotes to manufacturing our Assays from Shanghai Jing Ying Biotechnology Co. and are now conducting due diligence.

3) Biomagnetics has entered into a memorandum of understanding whereby B.R.I.A. will undertake the responsibility to represent Biomagnetics Diagnostics Corp. in acquiring the required Health Ministry approvals to perform clinical trials in Thailand on the HTS-MTP Diagnostic System, including the Company's proprietary HIV and Hepatitis B assays.

About Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective.

For more information please visit: Welcome to Biomagnetics Diagnostics Corporation.

Forward-looking Statement:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Stockhideout and its affiliates have been compensated a total of twenty five thousand dollars for profile coverage of BMGP from a non-controlling third party. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

alexis · Tue, 03-11-2008, 05:45 PM

Another spur for this company but is still continuing formal negotiations with Tianjin, China Looking forward for merging companies and increase the company's profit.

A series of legal processes are involved while continuing to agree both ends meet.There will also be clinical trials as part of ensuring it's effectiveness and reliability to ensure trust and confidence.

alexis

jconway · Tue, 03-11-2008, 06:25 PM

Biomagnetics Diagnostics Corp. (BMGP) has the technology to duplicate infectious disease screening faster and cheaper than other biotech companies in the same arena!!

What this means to you is that their process will detect any virus or bacteria and count the viral load in a matter of minutes!! They also have the capability of screening several hundred percent more "assays", per hour, at a fraction of the cost of current technologies!!

Their technology can test using ANY bodily fluid, including: whole blood, serum, urine, saliva, hormonal fluid, semen, and spinal fluid.

BMGP's technology can give results as soon as the testing process ends and thus it saves a lot of time (and money!!). HTS-PTM system features include cost effectiveness, reliability and speed.

The Company is aggressively planning to expand its operations worldwide, which will increase the Company’s client base and thus increase profitability.

IMPORTANT NOTE: The Bill and Melinda Gates Foundation has donated $30 million to this industry to help better develop this and other types of DIAGNOSTICS TESTS!! That speaks volumes and is a confirmation of how huge this industry is!!

otcbulldog · Tue, 03-11-2008, 06:38 PM

Here's the Opportunity:

BMGP offers a unique opportunity to profit from a revolutionary diagnostic system that can offer the medical industry a unique method that provides confirmatory and viral load diagnostics at the same costs of screening assays.

Early investors can also participate in broad revenue streams generated by sales and licensing fees. The Company’s most likely exit pathway is a strategic merger or acquisition, which would be ideal for investor liquidity.

BMGP is in a massive market! The Company defines its markets for the first line of products as public and private laboratories and blood banks.

According to Frost & Sullivan the global size of the “Medical Device Market” exceeds $200 billion and the U.S. retail market exceeds $56 billion!!

BMGP's doing big things internationally too!! The company has partnered with the largest social institute in Latin America, Instituto Mexicana del Seguro Social ("IMSS"), to conduct clinical trials in Mexico. The company has been assigned to Dr. Jose Dante Amato Martinez with IMSS who will be the company's coordinator, and has agreed to jointly conduct research, develop protocols and perform clinical trials to validate the company's HTS-MTP technology, leading to the commercialization of the company's products in Mexico.

Amato has already introduced the company to leading IMSS doctors across Mexico that will be heading the project and developing the necessary protocols.

The full profile is located at TWINTRADER

bullpicks6 · Wed, 03-12-2008, 09:54 AM

we're looking good here today, I may accumulate some more, it just feels like the calm before the storm if you will

stockwhiz85 · Wed, 03-12-2008, 06:02 PM

BMGP'S HTS-MTP system performs the screening, confirmatory and viral load test in a single function for the single cost of $2.50 - this would translate into huge savings in healthcare by narrowing down the three step diagnostic process (screening, confirmatory, viral load testing) into a single effective and cost-efficient test.

bullpicks6 · Thu, 03-13-2008, 09:05 AM

BMGP nice gapping up...

stockwhiz85 · Thu, 03-13-2008, 06:02 PM

nice and decent day today, volume just keeps on getting bullish!!! hoping for good news soon then we'll have this in full blast!!!

stockwhiz85 · Mon, 03-17-2008, 01:54 PM

Quote:

Originally Posted by stockwhiz85

BMGP'S HTS-MTP system performs the screening, confirmatory and viral load test in a single function for the single cost of $2.50 - this would translate into huge savings in healthcare by narrowing down the three step diagnostic process (screening, confirmatory, viral load testing) into a single effective and cost-efficient test.

BMGP's technology is something that we can't simply put down if we are to revolutionize this side of biotechnology, in a cost efficient and cost effective way - BMGP's HTS-MTP diagnostic system is going to make it big!

stockwhiz85 · Wed, 03-19-2008, 03:03 PM

The U.S. Patent Office has granted Biomagnetics Diagnostics Corporation (BMGP) the right to file for international patent protection.

President and CEO, Clayton Hardman states “We are very excited for this FILING OF DEMAND on our second product. It is very important that we position ourselves with multiple products and to be protected internationally”

Mr. Hardman continues “It is essential that a company does not place all of its eggs in one basket, by continually developing additional products we insure Biomagnetics success.

About Biomagnetics System second product:

The Company’s second product is a new diagnostic system designed for multi-analyte testing for blood banks titled “SYSTEM AND METHOD FOR DETECTING SPECIFIC BINDING REACTIONS USING MAGNETIC LABELS”. This technology uses a combination of opposing magnetic fields and light refraction.

Blood banks receive and test approximately 14 million units of blood annually. Each unit is tested for 9 infectious diseases totaling 126 million diagnostics tests. We hope to bring this new system to market in 2009. The costs of performing these diagnostics including assays, staffing and general overhead which exceeds all revenues. Our system will perform all 9 required tests in a single assay thus substantially reducing the costs blood banks will incur.

Generally speaking all blood banks operate in the red. We believe our new system will save 30 to 40 percent on blood diagnostics and turn their red into black overnight.

About Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective.

For more information please visit: www.biomagcorp.com

Forward-looking Statement:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Contacts:

Biomagnetics Diagnostics
Paul Hardman
paul@biomagneticsbmgp.com

Tue, 03-11-2008, 04:15 PM	#1 (permalink)
admin Administrator Join Date: Mar 2005 Posts: 58	BMGP - Biomagnetics Corp *Current Project for Biomagnetics Diagnostics Corp* 4:26p ET March 10, 2008 (Business Wire) Biomagnetics Diagnostics Corporation (OTC:BMGP), announced today that is continuing formal negotiations to purchase an interest in Tianjin Automatic Science & Instrument Co. LTD. 1) Auto Science is located in Tianjin, China's third largest city with a population of 9.5 million. Tianjin is a major comprehensive industrial base in northern China. It has over 150 lines of industry consisting primarily of electronics, automobile, metallurgy, pharmaceuticals, textiles, chemicals and mechanics. Tianjin Auto Science has been in business over 15 years. By acquiring an interest in Tianjin Auto Science, Biomagnetics Diagnostics will gain access to over 1,250 distributors, a laboratory client base of 10,000 and skilled manufacturing in the business community's most exciting markets. 2) We have received quotes to manufacturing our Assays from Shanghai Jing Ying Biotechnology Co. and are now conducting due diligence. 3) Biomagnetics has entered into a memorandum of understanding whereby B.R.I.A. will undertake the responsibility to represent Biomagnetics Diagnostics Corp. in acquiring the required Health Ministry approvals to perform clinical trials in Thailand on the HTS-MTP Diagnostic System, including the Company's proprietary HIV and Hepatitis B assays. About Biomagnetics Diagnostics Corporation Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective. For more information please visit: Welcome to Biomagnetics Diagnostics Corporation. Forward-looking Statement: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Stockhideout and its affiliates have been compensated a total of twenty five thousand dollars for profile coverage of BMGP from a non-controlling third party. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements. __________________ Information brought to you courtesy of ActionCapitalGroupe.com La Centrale Small Caps en Francais

Tue, 03-11-2008, 06:25 PM	#3 (permalink)
jconway Join Date: Nov 2007 Posts: 10	I like what BMGP is doing!! Biomagnetics Diagnostics Corp. (BMGP) has the technology to duplicate infectious disease screening faster and cheaper than other biotech companies in the same arena!! What this means to you is that their process will detect any virus or bacteria and count the viral load in a matter of minutes!! They also have the capability of screening several hundred percent more "assays", per hour, at a fraction of the cost of current technologies!! Their technology can test using ANY bodily fluid, including: whole blood, serum, urine, saliva, hormonal fluid, semen, and spinal fluid. BMGP's technology can give results as soon as the testing process ends and thus it saves a lot of time (and money!!). HTS-PTM system features include cost effectiveness, reliability and speed. The Company is aggressively planning to expand its operations worldwide, which will increase the Company’s client base and thus increase profitability. IMPORTANT NOTE: The Bill and Melinda Gates Foundation has donated $30 million to this industry to help better develop this and other types of DIAGNOSTICS TESTS!! That speaks volumes and is a confirmation of how huge this industry is!!

Tue, 03-11-2008, 06:38 PM	#4 (permalink)
otcbulldog Join Date: Nov 2007 Posts: 4	BMGP - Hot BioTech Company!! Here's the Opportunity: BMGP offers a unique opportunity to profit from a revolutionary diagnostic system that can offer the medical industry a unique method that provides confirmatory and viral load diagnostics at the same costs of screening assays. Early investors can also participate in broad revenue streams generated by sales and licensing fees. The Company’s most likely exit pathway is a strategic merger or acquisition, which would be ideal for investor liquidity. BMGP is in a massive market! The Company defines its markets for the first line of products as public and private laboratories and blood banks. According to Frost & Sullivan the global size of the “Medical Device Market” exceeds $200 billion and the U.S. retail market exceeds $56 billion!! BMGP's doing big things internationally too!! The company has partnered with the largest social institute in Latin America, Instituto Mexicana del Seguro Social ("IMSS"), to conduct clinical trials in Mexico. The company has been assigned to Dr. Jose Dante Amato Martinez with IMSS who will be the company's coordinator, and has agreed to jointly conduct research, develop protocols and perform clinical trials to validate the company's HTS-MTP technology, leading to the commercialization of the company's products in Mexico. Amato has already introduced the company to leading IMSS doctors across Mexico that will be heading the project and developing the necessary protocols. *The full profile is located at TWINTRADER*

Wed, 03-12-2008, 06:02 PM	#6 (permalink)
stockwhiz85 Super Moderator Join Date: Jan 2007 Posts: 239	BMGP - Revolutionizing In-Vitro Testing Industry BMGP'S HTS-MTP system performs the screening, confirmatory and viral load test in a single function for the single cost of $2.50 - this would translate into huge savings in healthcare by narrowing down the three step diagnostic process (screening, confirmatory, viral load testing) into a single effective and cost-efficient test. Last edited by stockwhiz85 : Wed, 03-12-2008 at 06:18 PM.

Thu, 03-13-2008, 06:02 PM	#8 (permalink)
stockwhiz85 Super Moderator Join Date: Jan 2007 Posts: 239	a nice day today! nice and decent day today, volume just keeps on getting bullish!!! hoping for good news soon then we'll have this in full blast!!! Last edited by stockwhiz85 : Thu, 03-13-2008 at 06:36 PM.

Tue, 03-11-2008, 05:45 PM	#2 (permalink)
alexis Member Join Date: Feb 2008 Posts: 27	Another spur for this company but is still continuing formal negotiations with Tianjin, China Looking forward for merging companies and increase the company's profit. A series of legal processes are involved while continuing to agree both ends meet.There will also be clinical trials as part of ensuring it's effectiveness and reliability to ensure trust and confidence. alexis

Wed, 03-12-2008, 09:54 AM	#5 (permalink)
bullpicks6 Member Join Date: Mar 2007 Posts: 21	we're looking good here today, I may accumulate some more, it just feels like the calm before the storm if you will

Thu, 03-13-2008, 09:05 AM	#7 (permalink)
bullpicks6 Member Join Date: Mar 2007 Posts: 21	BMGP nice gapping up...

Wed, 03-19-2008, 03:03 PM	#10 (permalink)
stockwhiz85 Super Moderator Join Date: Jan 2007 Posts: 239	Biomagnetics Diagnostics Corp. Inc. Announces Patent Protection The U.S. Patent Office has granted Biomagnetics Diagnostics Corporation (BMGP) the right to file for international patent protection. President and CEO, Clayton Hardman states “We are very excited for this FILING OF DEMAND on our second product. It is very important that we position ourselves with multiple products and to be protected internationally” Mr. Hardman continues “It is essential that a company does not place all of its eggs in one basket, by continually developing additional products we insure Biomagnetics success. About Biomagnetics System second product: The Company’s second product is a new diagnostic system designed for multi-analyte testing for blood banks titled “SYSTEM AND METHOD FOR DETECTING SPECIFIC BINDING REACTIONS USING MAGNETIC LABELS”. This technology uses a combination of opposing magnetic fields and light refraction. Blood banks receive and test approximately 14 million units of blood annually. Each unit is tested for 9 infectious diseases totaling 126 million diagnostics tests. We hope to bring this new system to market in 2009. The costs of performing these diagnostics including assays, staffing and general overhead which exceeds all revenues. Our system will perform all 9 required tests in a single assay thus substantially reducing the costs blood banks will incur. Generally speaking all blood banks operate in the red. We believe our new system will save 30 to 40 percent on blood diagnostics and turn their red into black overnight. About Biomagnetics Diagnostics Corporation Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective. For more information please visit: www.biomagcorp.com Forward-looking Statement: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events of future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluation such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements. Contacts: Biomagnetics Diagnostics Paul Hardman paul@biomagneticsbmgp.com

Thread Tools	Search this Thread
Show Printable Version Email this Page	Search this Thread: Advanced Search
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode